FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to narcology, and is designed for evaluation of occurrence of mental and behavioral disorders caused by intravenous application of psychoactive substances. Level of clinical signs of immune deficiency is detected, lower pain threshold, hostility index, level of state anxiety, attitude to isopropanol is measured using a visual analogue scale. Risk of disorders with intravenous application of psychoactive substances is measured by mathematical formula. Depending on the obtained value of calculation result, high risk of disorders or low risk of disorders is determined.
EFFECT: method allows to evaluate the level of risk of mental and behavioral disorders caused by intravenous application of psychoactive substances, and to carry out preventive actions timely due to determination of prognostic indices.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EVALUATION OF DEPENDENCE SYNDROME RELAPSE RISK AFTER FORCED ABSTINENCE FROM DRUGS FOR UNDERAGE MALES | 2010 |
|
RU2438587C1 |
| DIAGNOSTIC TECHNIQUE FOR PROPENSITY OF YOUTH FOR ABUSING PSYCHOACTIVE SUBSTANCES | 2008 |
|
RU2372031C1 |
| METHOD OF ESTIMATING RISK OF EPISODIC INTAKE OF DRUGS BY PEOPLE OF ADOLESCENT AGE | 2012 |
|
RU2495622C1 |
| METHOD FOR PSYCHOLOGICAL TRAINING BY 'PREVENTIVE DRAMA THERAPY' TECHNIQUE | 2011 |
|
RU2466752C1 |
| METHOD OF THE PANIC DISORDER FORMING RISK PREDICTING AT THE EARLY STAGE OF DISEASE | 2016 |
|
RU2644309C1 |
| METHOD FOR ASSESSING THE RISK OF SUICIDAL BEHAVIOR OF PATIENTS WITH BIPOLAR AFFECTIVE DISORDER | 2019 |
|
RU2726470C1 |
| USE OF MAVOGLURANT TO REDUCE COCAINE INTAKE OR TO PREVENT RECURRENT COCAINE INTAKE | 2018 |
|
RU2804834C2 |
| METHOD FOR PREDICTING THERAPY EFFICIENCY FOR PATIENTS WITH ADJUSTMENT DISORDERS WITH ANXIETY-DEPRESSIVE SYMPTOMATIC | 2018 |
|
RU2677867C1 |
| METHOD OF DETERMINING THE RISK OF FORMING ADDITIVE BEHAVIOR | 2016 |
|
RU2621278C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PANIC DISORDER AND ORGANIC ANXIOUS DISORDER IN CONNECTION WITH VASCULAR DISEASE OF THE BRAIN | 2021 |
|
RU2770734C1 |
